Physician

Adel I Youssef, M.D.

According to 2025 Medicare claims, Adel Youssef, M.D. (NPI: 1891788477) practices gastroenterology in the Youngstown-Warren, OH market, with the plurality of this provider's patient population coming from Trumbull, OH. This provider's primary affiliated billing organization is THE GASTROENTEROLOGY CLINIC & ENDOSCOPY CENTER INC (NPI: 1952497117; TIN: 341827025) and primary practice location at 44483-6613. Youssef is affiliated with the Main Street Rural Health Dogwood ACO LLC (ACO ID: A5421), participating under the MSSP model.

Youssef's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 118 traditional Medicare patients, billed 182 HCPCS/CPT codes, and received $14,492 in Medicare payments. The top billing code was 45380 (Biopsy of large bowel using a flexible endoscope). Part D data shows 3,405 prescription claims across 895 beneficiaries totaling $908,584 in drug costs, led by Creon (Lipase/Protease/Amylase). DME data shows 22 claims. Open Payments data shows 28 records totaling $554. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has fallen sharply in recent years, from $137,798 to $14,492. Similarly, Part D prescription costs have moved from a higher plateau to a lower plateau, from $1,814,964 to $908,584. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	677	1,503	$137,798
2016	700	1,538	$141,278
2017	602	1,196	$107,687
2018	575	1,182	$102,813
2019	575	1,125	$100,774
2020	387	744	$66,361
2021	386	768	$73,207
2022	534	931	$81,389
2023	234	953	$44,520
2024	118	182	$14,492

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	1,321	5,159	$1,814,964
2016	1,183	4,688	$1,595,296
2017	1,254	4,901	$892,824
2018	1,322	5,141	$1,069,840
2019	1,314	4,950	$1,151,010
2020	1,158	4,329	$757,976
2021	1,253	4,757	$703,429
2022	1,305	5,932	$810,589
2023	1,232	5,291	$963,779
2024	895	3,405	$908,584

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	22	$259

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
45380	Biopsy of large bowel using a flexible endoscope	24	24	$96
43249	Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm	12	13	$93
99203	New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more	16	16	$82
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	35	38	$61
43239	Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope	24	25	$43

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Creon	Lipase/Protease/Amylase	23	998	$107,650
Linzess	Linaclotide	165	5,850	$103,371
Zenpep	Lipase/Protease/Amylase	25	753	$89,456
Ibsrela	Tenapanor Hcl	29	1,050	$61,140
Xifaxan	Rifaximin	16	480	$53,605

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
K0001	Standard wheelchair	Y	N/R	11	$178
K0195	Elevating leg rests, pair (for use with capped rental wheelchair base)	Y	N/R	11	$81

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	28	$554	Takeda Pharmaceuticals U.S.A., Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Adel I. Youssef, M.D.?

Tedicare shows public-source Medicare data for Adel I. Youssef, M.D. (NPI 1891788477), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Adel I. Youssef, M.D. have ACO affiliation data?

Adel I. Youssef, M.D. is shown with ACO affiliation data for Main Street Rural Health Dogwood ACO LLC (MSSP, ACO ID A5421).

What billing organization is linked to Adel I. Youssef, M.D.?

Adel I. Youssef, M.D. is linked to THE GASTROENTEROLOGY CLINIC & ENDOSCOPY CENTER INC (billing NPI 1952497117) in the available physician profile data.

Does Adel I. Youssef, M.D. have Open Payments data?

Adel I. Youssef, M.D. has 28 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.